Abstract:G protein-coupled receptors (GPCRs), as the largest family of membrane receptors, actively modulate plasma membrane and endosomal signalling. Importantly, GPCRs are naturally nanosized, and spontaneously formed nanoaggregates of GPCRs (natural nano-GPCRs) may enhance GPCR-related signalling and functions. Although GPCRs are the molecular targets of the majority of marketed drugs, the poor pharmacokinetics and physicochemical properties of GPCR ligands greatly limit their clinical applicability. Nanotechnology, as versatile techniques, can encapsulate GPCR ligands to assemble synthetic nano-GPCRs to overcome their obstacles, robustly elevating drug efficacy and safety. Moreover, endosomal delivery of GPCR ligands by nanoparticles can precisely initiate sustained endosomal signal transduction, while nanotechnology has been widely utilized for isolation, diagnosis, and detection of GPCRs. In turn, due to overexpression of GPCRs on the surface of various types of cells, GPCR ligands can endow nanoparticles with active targeting capacity for specific cells via ligand-receptor binding and mediate receptor-dependent endocytosis of nanoparticles. This significantly enhances the potency of nanoparticle delivery systems. Therefore, emerging evidence has revealed the interplay between GPCRs and nanoparticles, although investigations into their relationship have been inadequate. This review aims to summarize the interaction between GPCRs and nanotechnology for understanding their mutual influences and utilizing their interplay for biomedical applications. It will provide a fundamental platform for developing powerful and safe GPCR-targeted drugs and nanoparticle systems. STATEMENT OF SIGNIFICANCE: GPCRs as molecular targets for the majority of marketed drugs are naturally nanosized, and even spontaneously form nano aggregations (nano-GPCRs). Nanotechnology has also been applied to construct synthetic nano-GPCRs or detect GPCRs, while endosomal delivery of GPCR ligands by nanoparticles can magnify endosomal signalling. Meanwhile, molecular engineering of nanoparticles with GPCRs or their ligands can modulate membrane binding and endocytosis, powerfully improving the efficacy of nanoparticle system. However, there are rare summaries on the interaction between GPCRs and nanoparticles. This review will not only provide a versatile platform for utilizing nanoparticles to modulate or detect GPCRs, but also facilitate better understanding of the designated value of GPCRs for molecular engineering of biomaterials with GPCRs in therapeutical application.

Small GTPases: Structure, biological function and its interaction with nanoparticles

Regulation the Morphology of Micro-and Nanoparticles and the Effect on Drug/Gene Delivery System

Early-stage structure-based drug discovery for small GTPases by NMR spectroscopy

Interplay Between G Protein-Coupled Receptors and Nanotechnology

Structural Insights into the Regulation Mechanism of Small GTPases by GEFs

Computational Studies on the Interactions of Nanomaterials with Proteins and Their Impacts

Nanoparticle Ligand Exchange and Its Effects at the Nanoparticle-Cell Membrane Interface

Ubiquitination-Dependent Regulation of Small GTPases in Membrane Trafficking: From Cell Biology to Human Diseases

Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS

A universal strategy of facilitating intracellular delivery of nanomedicines based on tuning ARF6 GTPase to its GTP-bound form

Advances in the Development of Rho GTPase Inhibitors

The Impact of Rho GTPases on the Cell Uptake of Single-Walled Carbon Nanohorns

Biological Interaction and Imaging of Ultrasmall Gold Nanoparticles

Evaluation of Turning-Sized Gold Nanoparticles on Cellular Adhesion by Golgi Disruption in Vitro and in Vivo

Trimming nano delivery at the cell side by tuning ARF6 GTPases to the GTP-bound form

Unique Roles of Gold Nanoparticles in Drug Delivery, Targeting and Imaging Applications

Gold Nanoparticles in Cancer Theranostics

Function and regulation of Rab GTPases in cancers

Tuning of Ultrasmall Gold Nanoparticles Surface Properties Affect Their Biological Fate

Development and therapeutic potential of GSPT1 molecular glue degraders: A medicinal chemistry perspective

The role of the Rho family small GTPases in regulation of normal and pathological processes